160 related articles for article (PubMed ID: 36569862)
61. Dickkopf-1 inhibits thyroid cancer cell survival and migration through regulation of β-catenin/E-cadherin signaling.
Cho SW; Lee EJ; Kim H; Kim SH; Ahn HY; Kim YA; Yi KH; Park DJ; Shin CS; Ahn SH; Cho BY; Park YJ
Mol Cell Endocrinol; 2013 Feb; 366(1):90-8. PubMed ID: 23261982
[TBL] [Abstract][Full Text] [Related]
62. Low density lipoprotein receptor-related protein 5 gene polymorphisms and osteoporosis in Thai menopausal women.
Kitjaroentham A; Hananantachai H; Phonrat B; Preutthipan S; Tungtrongchitr R
J Negat Results Biomed; 2016 Sep; 15(1):16. PubMed ID: 27582019
[TBL] [Abstract][Full Text] [Related]
63. WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors.
Pannone G; Bufo P; Santoro A; Franco R; Aquino G; Longo F; Botti G; Serpico R; Cafarelli B; Abbruzzese A; Caraglia M; Papagerakis S; Lo Muzio L
Oncol Rep; 2010 Oct; 24(4):1035-41. PubMed ID: 20811686
[TBL] [Abstract][Full Text] [Related]
64. Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity.
Ellies DL; Viviano B; McCarthy J; Rey JP; Itasaki N; Saunders S; Krumlauf R
J Bone Miner Res; 2006 Nov; 21(11):1738-49. PubMed ID: 17002572
[TBL] [Abstract][Full Text] [Related]
65. Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men.
Kiel DP; Ferrari SL; Cupples LA; Karasik D; Manen D; Imamovic A; Herbert AG; Dupuis J
Bone; 2007 Mar; 40(3):587-96. PubMed ID: 17137849
[TBL] [Abstract][Full Text] [Related]
66. Interaction between LRP5 and periostin gene polymorphisms on serum periostin levels and cortical bone microstructure.
Pepe J; Bonnet N; Herrmann FR; Biver E; Rizzoli R; Chevalley T; Ferrari SL
Osteoporos Int; 2018 Feb; 29(2):339-346. PubMed ID: 29038835
[TBL] [Abstract][Full Text] [Related]
67. Oligomerization of Frizzled and LRP5/6 protein initiates intracellular signaling for the canonical WNT/β-catenin pathway.
Hua Y; Yang Y; Li Q; He X; Zhu W; Wang J; Gan X
J Biol Chem; 2018 Dec; 293(51):19710-19724. PubMed ID: 30361437
[TBL] [Abstract][Full Text] [Related]
68. Role of Sost in Wnt signal pathway in osteoporosis rats and regulating effect of soybean isoflavones on Wnt signal pathway.
Liang HD; Yu F; Lv P; Zhao ZN; Tong ZH
Mol Biol Rep; 2014 Jul; 41(7):4447-54. PubMed ID: 24760368
[TBL] [Abstract][Full Text] [Related]
69. Infection-induced signals generated at the plasma membrane epigenetically regulate Wnt signaling
Ahmed I; Roy BC; Rao Jakkula LUM; Subramaniam D; Dandawate P; Anant S; Sampath V; Umar S
J Biol Chem; 2020 Jan; 295(4):1021-1035. PubMed ID: 31836665
[TBL] [Abstract][Full Text] [Related]
70. Serum levels of sclerostin, Dickkopf-1, and secreted frizzled-related protein-4 are not changed in individuals with high bone mass causing mutations in LRP5.
Simpson CA; Foer D; Lee GS; Bihuniak J; Sun B; Sullivan R; Belsky J; Insogna KL
Osteoporos Int; 2014 Oct; 25(10):2383-8. PubMed ID: 24927689
[TBL] [Abstract][Full Text] [Related]
71. Lack of association of LRP5 and LRP6 polymorphisms with type 2 diabetes mellitus in the Japanese population.
Zenibayashi M; Miyake K; Horikawa Y; Hirota Y; Teranishi T; Kouyama K; Sakaguchi K; Takeda J; Kasuga M
Endocr J; 2008 Aug; 55(4):699-707. PubMed ID: 18493104
[TBL] [Abstract][Full Text] [Related]
72. Negative regulation of LRP6 function by casein kinase I epsilon phosphorylation.
Swiatek W; Kang H; Garcia BA; Shabanowitz J; Coombs GS; Hunt DF; Virshup DM
J Biol Chem; 2006 May; 281(18):12233-41. PubMed ID: 16513652
[TBL] [Abstract][Full Text] [Related]
73. Polymorphisms in Wnt signaling pathway genes are associated with peak bone mineral density, lean mass, and fat mass in Chinese male nuclear families.
Zheng Y; Wang C; Zhang H; Shao C; Gao LH; Li SS; Yu WJ; He JW; Fu WZ; Hu YQ; Li M; Liu YJ; Zhang ZL
Osteoporos Int; 2016 May; 27(5):1805-15. PubMed ID: 26733379
[TBL] [Abstract][Full Text] [Related]
74. Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells.
Fenderico N; van Scherpenzeel RC; Goldflam M; Proverbio D; Jordens I; Kralj T; Stryeck S; Bass TZ; Hermans G; Ullman C; Aastrup T; Gros P; Maurice MM
Nat Commun; 2019 Jan; 10(1):365. PubMed ID: 30664649
[TBL] [Abstract][Full Text] [Related]
75. Glucocorticoid therapy suppresses Wnt signaling by reducing the ratio of serum Wnt3a to Wnt inhibitors, sFRP-1 and Wif-1.
Kawazoe M; Kaneko K; Nanki T
Clin Rheumatol; 2021 Jul; 40(7):2947-2954. PubMed ID: 33420868
[TBL] [Abstract][Full Text] [Related]
76. Reversing LRP5-dependent osteoporosis and SOST deficiency-induced sclerosing bone disorders by altering WNT signaling activity.
Chang MK; Kramer I; Keller H; Gooi JH; Collett C; Jenkins D; Ettenberg SA; Cong F; Halleux C; Kneissel M
J Bone Miner Res; 2014 Jan; 29(1):29-42. PubMed ID: 23901037
[TBL] [Abstract][Full Text] [Related]
77. Tyrosine-based signal mediates LRP6 receptor endocytosis and desensitization of Wnt/β-catenin pathway signaling.
Liu CC; Kanekiyo T; Roth B; Bu G
J Biol Chem; 2014 Oct; 289(40):27562-70. PubMed ID: 25143377
[TBL] [Abstract][Full Text] [Related]
78. Coexpression of SFRP1 and WIF1 as a prognostic predictor of favorable outcomes in patients with colorectal carcinoma.
Huang S; Zhong X; Gao J; Song R; Wu H; Zi S; Yang S; Du P; Cui L; Yang C; Li Z
Biomed Res Int; 2014; 2014():256723. PubMed ID: 24949429
[TBL] [Abstract][Full Text] [Related]
79. Genetic Variants in the Wnt/β-Catenin Signaling Pathway as Indicators of Bladder Cancer Risk.
Pierzynski JA; Hildebrandt MA; Kamat AM; Lin J; Ye Y; Dinney CP; Wu X
J Urol; 2015 Dec; 194(6):1771-6. PubMed ID: 26173102
[TBL] [Abstract][Full Text] [Related]
80. Association Between Genetic Polymorphisms of lncRNA
Li HM; Wang LJ; Tang F; Pan HF; Zhang TP
Infect Drug Resist; 2022; 15():2481-2489. PubMed ID: 35586561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
